Levothyroxine Sodium
左甲状腺素钠
Report date: 2026/05/20 20:02:01
NME
Base Information
Drug NameLevothyroxine Sodium
Drug Alias Name +[19]
Classification
Mechanisms of Action
Targets
Therapy Area/Indications +[22]
Global Approved Indications
Approved Indications in China
Original Approved Country/Territory
Original Approved Date2000/01/01
Country/Territory +[12]
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesAbbvie Inc
China Registration ClassN/A
Develop Information
Active CompaniesMerck Healthcare Kgaa, Darmstadt, Germany, An Affiliate Of Merck Kgaa, Darmstadt, GermanyUniversity Of California San FranciscoCairo University +[13]
Inactive CompaniesUniversidad Autonoma de Nuevo LeonGeorgetown UniversityNeuvosyn Laboratories, LLC +[13]
Active Indications +[15]
Inactive Indications +[7]